Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Breath-activated inhaler from IVAX licensed to Glaxo Wellcome

Dec. 31, 1996

Endorex licenses oral delivery technology

Dec. 24, 1996

Novel adenylate cyclase offered for licensing

Dec. 20, 1996

MRC offers licenses for work relating to pathological vasoconstriction

Dec. 20, 1996

Genelabs-DuPont Merck joint effort to discover gene-regulating drugs

Dec. 20, 1996

FDA medical devices advisory committee to meet today

Dec. 20, 1996

Knoll licenses technology for use in cardiovascular research

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Inactivation of SIV by LifeTECH's blood sterilization technology

Dec. 17, 1996

Celox Laboratories' ViaStem receives patent coverage

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...